Joseph Gentile brings over 30 years of business experience to the team. 

• Joe’s career as an operating executive, board member and investor has spanned medical devices, diagnostics, life science tools and cell therapy platforms and services. 

• He began his career in early-stage startups, later moving to HP Medical Products Group (now Philips Medical Systems) where he spent 10 years in engineering, marketing and corporate strategy roles.

• Following HP, Joe spent 14 years at Becton Dickinson in corporate strategy, global business unit general management, and corporate venture investments.

• Recently, Joe was CEO and board member at Cellero Biosciences (acquired by Charles River Labs) and Stemgent Inc (acquired by ReproCell Group of Japan). 

• Joe is an active angel investor and has investments in companies at the forefront of cell therapy and life science tools, diagnostics, and green technologies.